Geneva, Feb. 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119060) titled 'Clinical Application of Remimazolam in Cardiac Patients Undergoing Non-Cardiac Surgery Based on Non-Invasive Cardiac Output Monitoring' on Feb. 14.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The First People's Hospital of Changzhou
Condition:
heart disease
Intervention:
Low Remimazolam Group:General anesthesia was induced with remimazolam at 0.2 mg/kg.
Medium Remimazolam Group:General anesthesia was induced with remimazolam at 0.3mg/kg.
High Remimazolam Group:General anesthesia was induced with remimazolam at 0.4mg/kg.
Recruitment Status: Not Recruiting
Phase: 4
Date of F...